Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
Manuela Giansanti(University of Rome Tor Vergata), Isabella Faraoni(University of Rome Tor Vergata)
Cited by 10
Related Papers
BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2014|62